デフォルト表紙
市場調査レポート
商品コード
1605621

ホルモン性子宮内避妊器具(IUD)の世界市場レポート 2024年

Hormonal Intrauterine Devices (IUDs) Global Market Report 2024


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
ホルモン性子宮内避妊器具(IUD)の世界市場レポート 2024年
出版日: 2024年12月03日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ホルモン性子宮内避妊器具(IUD)の市場規模は今後数年で急成長が見込まれます。2028年にはCAGR10.8%で39億3,000万米ドルに成長します。予測期間中に予想される成長の要因としては、避妊法の選択肢に対する意識の高まり、長時間作用型可逆的避妊法への嗜好の高まり、デバイスの安全性と有効性の進歩、個別化ヘルスケアの重視の高まり、医療提供者による幅広い利用可能性などが挙げられます。この期間に予想される主な動向には、デバイス技術の発展、避妊オプションの個別化の進展、患者中心のヘルスケアアプローチの成長、持続可能で環境に優しい製品に対する需要の高まり、新しい避妊製品の開発などがあります。

望まない妊娠の発生率の上昇が、今後のホルモン性子宮内避妊器具市場の成長を促進すると予測されています。望まない妊娠とは、妊娠時に計画されていなかったり望まれていなかったりする妊娠を指し、避妊の失敗、避妊具へのアクセス不足、避妊具の不適切な使用、性的暴力など、さまざまな要因から生じる可能性があります。効果的な避妊法へのアクセスが限られていると、生殖の選択に対する個人のコントロールが弱まり、望まない妊娠の可能性が高まる。ホルモンIUDは妊娠を防ぐのに非常に効果的で、失敗率は1%未満です。長期間の保護(種類によって3~7年)を提供し、意図しない妊娠を避けたい人にとって信頼できる選択肢となります。例えば、2023年8月、保健社会医療省内の英国政府機関である健康改善・格差対策室は、2022年1月から6月までの間に、イングランドとウェールズの住民の中絶件数は123,219件で、2021年の同時期と比べて17%増加したと報告しました。このように、望まない妊娠の増加がホルモン性子宮内避妊器具市場の成長に寄与しています。

ホルモン性子宮内避妊器具市場の主な企業は、レボノルゲストレル放出子宮内システムなどの先進的な製品の開発に注力し、女性により個別化された避妊ソリューションを提供しています。レボノルゲストレル放出子宮内避妊システム(LNG-IUS)は、子宮内に合成黄体ホルモンであるレボノルゲストレルを安定的に放出するホルモン性IUDです。このホルモンは子宮頸管粘液を濃くし、子宮内膜を変化させ、精子が卵子に到達するのを防ぐ。例えば、2022年11月、必須医薬品と健康製品への女性のアクセス改善に取り組む米国の製薬団体Medicines360は、FDA承認のLILETTAを発売しました。リレッタは米国で入手可能なホルモン性IUDの中で最も長持ちするもの一つで、避妊効果は最長8年、月経多量出血の治療効果は最長5年まで承認されています。このIUDは、さまざまな人々の妊娠を防ぐのに約99%の効果があります。人間工学に基づいた挿入器が付属しており、診察時に簡単に装着でき、ヘルスケアプロバイダーがいつでも取り外すことができます。処方箋により入手可能で、リレッタは340B薬価プログラムを通じて割引価格で提供され、女性のヘルスケアへのアクセスを強化するというMedicines360の使命に合致しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のホルモン性子宮内避妊器具(IUD)市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のホルモン性子宮内避妊器具(IUD)市場の実績:規模と成長, 2018-2023
  • 世界のホルモン性子宮内避妊器具(IUD)市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界のホルモン性子宮内避妊器具(IUD)市場:タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 13ミリグラムホルモン子宮内避妊器具
  • 19ミリグラムホルモン子宮内避妊器具
  • 52ミリグラムホルモン子宮内避妊器具
  • 世界のホルモン性子宮内避妊器具(IUD)市場:デザイン別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • フレーム付き子宮内避妊器具
  • フレームレス子宮内避妊器具
  • 世界のホルモン性子宮内避妊器具(IUD)市場:ホルモンの種類別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • レボノルゲストレル放出子宮内避妊器具
  • プロゲステロン放出子宮内避妊器具
  • 世界のホルモン性子宮内避妊器具(IUD)市場:用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 年齢20~24歳
  • 年齢25~34歳
  • 年齢35~44歳
  • その他の用途

第7章 地域別・国別分析

  • 世界のホルモン性子宮内避妊器具(IUD)市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のホルモン性子宮内避妊器具(IUD)市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ホルモン性子宮内避妊器具(IUD)市場:競合情勢
  • ホルモン性子宮内避妊器具(IUD)市場:企業プロファイル
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Bayer AG
    • Organon & Companies
    • Gedeon Richter Plc

第31章 その他の大手企業と革新的企業

  • Meril Life Science Pvt Ltd.
  • Bharat Serums and Vaccines Limited
  • Teva UK Limited
  • EurimPharm
  • HRA Pharma SAS
  • Medicines360
  • Hll Lifecare Limited
  • Pregna International Ltd.
  • Allergan plc
  • Actavis Inc.
  • DKT WomanCare Global
  • CrossBay Medical Inc.
  • SMB Corporation of India
  • Oy Leiras
  • OCON Healthcare

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r20265

Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices that are inserted into the uterus and release progestin, a synthetic hormone. These devices prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to impede implantation, and sometimes suppressing ovulation. Additionally, they can reduce menstrual bleeding and cramping, and in some cases, may stop periods altogether.

The primary types of hormonal IUDs include 13-milligram, 19-milligram, and 52-milligram hormonal IUDs. The 13-milligram hormonal IUDs, which release a low dose of hormones for up to three years, are becoming increasingly popular among women seeking long-acting contraceptive options with lower hormone exposure. The design of these devices varies, including framed and frameless IUDs, and they feature different hormone types such as levonorgestrel-releasing and progesterone-releasing IUDs. These options cater to various age groups, including those aged 20-24, 25-34, and 35-44, among other applications.

The hormonal intrauterine devices (IUDs) market research report is one of a series of new reports from The Business Research Company that provides hormonal intrauterine devices (IUDs) market statistics, including hormonal intrauterine devices (IUDs) industry global market size, regional shares, competitors with a hormonal intrauterine devices (IUDs) market share, detailed hormonal intrauterine devices (IUDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the hormonal intrauterine devices (IUDs) industry. This hormonal intrauterine device (IUDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal intrauterine devices (IUDs) market size has grown rapidly in recent years. It will grow from $2.36 billion in 2023 to $2.61 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth observed during the historic period can be attributed to several factors, including the development of safer and more effective hormonal formulations, a rising demand for long-term birth control solutions, increased recommendations from healthcare providers, greater public awareness of contraceptive options, and advancements in medical technology and device design.

The hormonal intrauterine devices (IUDs) market size is expected to see rapid growth in the next few years. It will grow to $3.93 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The anticipated growth during the forecast period can be attributed to several factors, including rising awareness of contraceptive choices, an increasing preference for long-acting reversible contraception, advancements in device safety and efficacy, a growing emphasis on personalized healthcare, and broader availability through healthcare providers. Key trends expected during this period include advancements in device technology, increasing personalization of contraceptive options, growth in patient-centric healthcare approaches, rising demand for sustainable and eco-friendly products, and the development of new contraceptive products.

The rising incidence of unwanted pregnancies is projected to drive the growth of the hormonal intrauterine devices market in the future. Unwanted pregnancies refer to those that are not planned or desired at the time of conception and can arise from various factors, such as contraceptive failure, lack of access to birth control, improper use of contraception, or sexual violence. Limited access to effective contraceptive methods diminishes individuals' control over their reproductive choices, increasing the likelihood of unwanted pregnancies. Hormonal IUDs are highly effective in preventing pregnancy, boasting a failure rate of less than 1%. They offer long-term protection (ranging from 3 to 7 years, depending on the specific type) and serve as a reliable option for those looking to avoid unintended pregnancies. For example, in August 2023, the Office for Health Improvement & Disparities, a UK governmental unit within the Department of Health and Social Care, reported that between January and June 2022, there were 123,219 abortions among residents of England and Wales, representing a 17% increase compared to the same period in 2021. Thus, the rise in unwanted pregnancies is contributing to the growth of the hormonal intrauterine devices market.

Key players in the hormonal intrauterine devices market are focusing on developing advanced products, such as levonorgestrel-releasing intrauterine systems, to offer more personalized contraceptive solutions for women. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal IUDs that steadily release levonorgestrel, a synthetic progestin, into the uterus. This hormone thickens cervical mucus and modifies the uterine lining, preventing sperm from reaching the egg. For instance, in November 2022, Medicines360, a US-based pharmaceutical organization dedicated to improving women's access to essential medicines and health products, launched the FDA-approved LILETTA. LILETTA is one of the longest-lasting hormonal IUDs available in the U.S., approved for contraception for up to 8 years and for treating heavy menstrual bleeding for up to 5 years. It is approximately 99% effective in preventing pregnancy among diverse populations. The device comes with an ergonomic inserter for easy placement during a consultation and can be removed at any time by a healthcare provider. It is available by prescription, and LILETTA is offered at a reduced price through the 340B drug pricing program, aligning with Medicines360's mission to enhance access to women's healthcare.

In January 2024, Medicines360 formed a partnership with DKT WomanCare Global, a France-based company focused on the availability, accessibility, and affordability of sexual and reproductive health products for women. This strategic collaboration aims to enhance the availability and accessibility of the affordable hormonal IUD, Avibela, by raising awareness and expanding market reach, particularly in underserved areas, and is intended to improve global sexual and reproductive health.

Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hormonal intrauterine devices (IUDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hormonal intrauterine devices (IUDs) market consists of sales of hormone reservoir, strings, and insertion or removal instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Intrauterine Devices (IUDs) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormonal intrauterine devices (IUDs) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal intrauterine devices (IUDs) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormonal intrauterine devices (IUDs) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: 13 Milligram Hormonal Intrauterine Devices; 19 Milligram Hormonal Intrauterine Devices; 52 Milligram Hormonal Intrauterine Devices
  • 2) By Device Design: Framed Intrauterine Devices; Frameless Intrauterine Devices
  • 3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices; Progesterone Releasing Intrauterine Devices
  • 4) By Application: Age 20-24; Age 25-34; Age 35-44; Other Applications
  • Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Organon & Companies; Gedeon Richter Plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormonal Intrauterine Devices (IUDs) Market Characteristics

3. Hormonal Intrauterine Devices (IUDs) Market Trends And Strategies

4. Hormonal Intrauterine Devices (IUDs) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Hormonal Intrauterine Devices (IUDs) Market Size and Growth

  • 5.1. Global Hormonal Intrauterine Devices (IUDs) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hormonal Intrauterine Devices (IUDs) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hormonal Intrauterine Devices (IUDs) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hormonal Intrauterine Devices (IUDs) Market Segmentation

  • 6.1. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 3 Milligram Hormonal Intrauterine Devices
  • 19 Milligram Hormonal Intrauterine Devices
  • 52 Milligram Hormonal Intrauterine Devices
  • 6.2. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Framed Intrauterine Devices
  • Frameless Intrauterine Devices
  • 6.3. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Levonorgestrel Releasing Intrauterine Devices
  • Progesterone Releasing Intrauterine Devices
  • 6.4. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Age 20-24
  • Age 25-34
  • Age 35-44
  • Other Applications

7. Hormonal Intrauterine Devices (IUDs) Market Regional And Country Analysis

  • 7.1. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market

  • 8.1. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hormonal Intrauterine Devices (IUDs) Market

  • 9.1. China Hormonal Intrauterine Devices (IUDs) Market Overview
  • 9.2. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hormonal Intrauterine Devices (IUDs) Market

  • 10.1. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hormonal Intrauterine Devices (IUDs) Market

  • 11.1. Japan Hormonal Intrauterine Devices (IUDs) Market Overview
  • 11.2. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hormonal Intrauterine Devices (IUDs) Market

  • 12.1. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hormonal Intrauterine Devices (IUDs) Market

  • 13.1. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hormonal Intrauterine Devices (IUDs) Market

  • 14.1. South Korea Hormonal Intrauterine Devices (IUDs) Market Overview
  • 14.2. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hormonal Intrauterine Devices (IUDs) Market

  • 15.1. Western Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • 15.2. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hormonal Intrauterine Devices (IUDs) Market

  • 16.1. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hormonal Intrauterine Devices (IUDs) Market

  • 17.1. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hormonal Intrauterine Devices (IUDs) Market

  • 18.1. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hormonal Intrauterine Devices (IUDs) Market

  • 19.1. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hormonal Intrauterine Devices (IUDs) Market

  • 20.1. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market

  • 21.1. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • 21.2. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hormonal Intrauterine Devices (IUDs) Market

  • 22.1. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hormonal Intrauterine Devices (IUDs) Market

  • 23.1. North America Hormonal Intrauterine Devices (IUDs) Market Overview
  • 23.2. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hormonal Intrauterine Devices (IUDs) Market

  • 24.1. USA Hormonal Intrauterine Devices (IUDs) Market Overview
  • 24.2. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hormonal Intrauterine Devices (IUDs) Market

  • 25.1. Canada Hormonal Intrauterine Devices (IUDs) Market Overview
  • 25.2. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hormonal Intrauterine Devices (IUDs) Market

  • 26.1. South America Hormonal Intrauterine Devices (IUDs) Market Overview
  • 26.2. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hormonal Intrauterine Devices (IUDs) Market

  • 27.1. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hormonal Intrauterine Devices (IUDs) Market

  • 28.1. Middle East Hormonal Intrauterine Devices (IUDs) Market Overview
  • 28.2. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hormonal Intrauterine Devices (IUDs) Market

  • 29.1. Africa Hormonal Intrauterine Devices (IUDs) Market Overview
  • 29.2. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Company Profiles

  • 30.1. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape
  • 30.2. Hormonal Intrauterine Devices (IUDs) Market Company Profiles
    • 30.2.1. Merck & Co. Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. AbbVie Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Organon & Companies
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Gedeon Richter Plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Hormonal Intrauterine Devices (IUDs) Market Other Major And Innovative Companies

  • 31.1. Meril Life Science Pvt Ltd.
  • 31.2. Bharat Serums and Vaccines Limited
  • 31.3. Teva UK Limited
  • 31.4. EurimPharm
  • 31.5. HRA Pharma SAS
  • 31.6. Medicines360
  • 31.7. Hll Lifecare Limited
  • 31.8. Pregna International Ltd.
  • 31.9. Allergan plc
  • 31.10. Actavis Inc.
  • 31.11. DKT WomanCare Global
  • 31.12. CrossBay Medical Inc.
  • 31.13. SMB Corporation of India
  • 31.14. Oy Leiras
  • 31.15. OCON Healthcare

32. Global Hormonal Intrauterine Devices (IUDs) Market Competitive Benchmarking

33. Global Hormonal Intrauterine Devices (IUDs) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hormonal Intrauterine Devices (IUDs) Market

35. Hormonal Intrauterine Devices (IUDs) Market Future Outlook and Potential Analysis

  • 35.1 Hormonal Intrauterine Devices (IUDs) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Hormonal Intrauterine Devices (IUDs) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Hormonal Intrauterine Devices (IUDs) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer